The program Congress established to speed commercial development of vaccines and treatments to counter a potential bioterror attack is moving too slowly ...
Legislation is being introduced again this year intended to go beyond Project Bioshield in promoting development of drugs that would be needed to treat victims of an act of biological terrorism. Reps.
HONOLULU (HawaiiNewsNow) - To mark Tsunami Awareness Month and Earth Month, Dr. Scott Fisher, Director of Aina Stewardship at the Hawaii Land Trust, joined HNN’s Sunrise Weekends to talk about the ...
CongressDaily reports that "the companies expected to participate in the program are not completely satisfied with it" (CongressDaily, 7/15). Companies would like to see revisions to the bill that ...
SAN FRANCISCO --By now, millions of anthrax vaccine shots developed through cutting-edge genetic engineering were supposed to be filling a new national stockpile of biodefense drugs. Instead, five ...
GERMANTOWN, Md., June 10, 2020 (GLOBE NEWSWIRE) -- Orgenesis Inc. (ORGS) (“Orgenesis” or the “Company”), a pioneering global biotech company committed to accelerating commercialization and ...
Less than a year after legislation to spur the development of new bioterror countermeasures became law, a policy debate is playing out in the Senate over what ...
WASHINGTON – President Bush is defending his administration's efforts to secure the homeland as this week's release of the Sept. 11 commission's (search) report reminds Americans of the nation's ...
SAN FRANCISCO — By now, millions of anthrax vaccine shots developed through cutting-edge genetic engineering were supposed to be filling a new national stockpile of biodefense drugs. Instead, five ...
Since it was introduced in 2003, the core of the BioShield program has been a slow-motion trainwreck. Hundreds of millions of dollars have been spent to get this new supply of vaccine -- with few ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results